IHC was carried out in 74 specimens to examine the expression of PD-L1, CD4, CD8, CD276 and SOCS3 in HCC patients who underwent surgical treatment, which was selected regarding to the AJCC guideline (Table 1). Here, CD8A is linked to hepatocellular carcinoma.